# Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/low-dose-abiraterone-in-metastatic-prostate-cancer-is-it-practice-changing-facts/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Amol Patel,Ian F. Tannock,Priyanka Srivastava,Bivas Biswas,Vineet Govinda Gupta,Atul Batra,Sainath Bhethanabhotla,Raja Pramanik,Shubh Mahindru,TVSVGK Tilak,Chandan Krushna Das,Prashant Mehta |
| Citations | 39 |
| DOI | 10.1200/jgo.19.00341 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JGO.19.00341 |
| OpenAlex ID | https://openalex.org/W3009821697 |
| PMID | 32125899 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Bivas Biswas](https://scholariq.org/researchers/bivas-biswas/)

## Paper primary topic

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Paper topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.